Antioxidantenzymes(AOEs),includingsuperoxidedismutaseisoenzymes(SOD), catalase(CAT),glutathioneperoxidase(GSH-Px)alongwithglutathionereductase (GR),reducedglutathione(GSH)andglutathionetransferase(GST),arethought tobenecessaryforlifeprocessesinalloxygen-metabolizingcellsbyremovingreactiveoxygenspecies(ROS).ThebiologicalsignificanceofAOEsintransformedcells isstillunclear,buttheircapacitytosurvivemaybeaffectedbychangesincellular processessuchasproliferation,invasiveness,migration,apoptosisanddrugresistance.Thisreviewsummarizesthesignificanceofantioxidantenzymesincancer cellprogressionmainlyinanin vitrocontext.
Introduction
Reactiveoxygenspecies(ROS)arechemicallyreactivemoleculessuchassuperoxideanions(O 2 -* ),hydroxylradicals(OH -* )andhydrogenperoxide(H 2 O 2 ) thathaveessentialfunctionsinlivingorganisms.ROS are constitutively produced by the mitochondrial electrontransportchainduringthecourseofcellular respiration,bycytochromeP450-relatedcomponents ofmicrosomes,lipoxygenase,cyclooxygenase [1] and inmanyhumantumorsandnormalcounterpartsby NADPHoxidase [2] .ROSproductionincancercells alsousuallyoccursfollowingexposuretochemotherapeuticdrugssuchasdoxorubicin,vinblastine,paclitaxelandplatinumcompounds,leadingtomultiple cellularresponsestooxidativestress [3] [4] [5] [6] [7] [8] .
TumorcellshavehigherlevelsofROSthannormal cells.AmoderateincreaseinROSproductionincan-cercellscanpromotecellproliferationanddifferentiation [9, 10] .Ontheotherhand,excessiveamounts ofROScancauseoxidativedamagetoproteins,DNA and lipids, acting as toxic agents [11] . Cancer cells with increased levels of ROS are likely to be more vulnerabletodamagebyfurtherROSinsultsinduced byexogenousagentssuchaschemotherapeuticdrugs [12] [13] [14] .Nevertheless,cancercellscanalsoadaptto surviveundercertainlevelsofoxidativestress,mainly duetoincreasedactivityofantioxidantenzymes [12, 15] .Thisoxidativeadaptationprocessmaycontributetocancercellprogressionviainducingproliferationofcancercellsinprimarytumors,activatingan invasionpotentialordrugresistancephenotype [16] .
Livingorganismspossessantioxidantmechanisms, whichprotectnormalandmalignantcellsfromROS levelsunderphysiologicalconditionsandwhichconsistofenzymesandnon-specificantioxidants.These enzymesincludecopper-andzinc-containingsuperoxidedismutase(Cu/ZnSODalsotermedSod-1),manganese-dependentsuperoxidedismutase(MnSODalso knownasSod-2),glutathioneperoxidase(GSH-Px), and catalase (CAT). Malondialdehyde (MDA) is a marker of lipid peroxidation [17] [18] [19] . Superoxide dismutase (SOD) catalyzes the conversion of O 2 to H 2 O 2 ,whichcanthenbeconvertedtowaterbycatalase (CAT) or glutathione peroxidase (GSH-Px) coupled with glutathione reductase (GR) [17, 18] . TherearetwomainformsofSODineukaryoticcells: Sod-1, also known as copper-and zinc-containing superoxidedismutase,primarylocatedinthecytosol butalsointhenucleus;andSod-2,alsonamedmanganese-dependent superoxide dismutase (MnSOD), sited in the mitochondrial matrix [20] . The GSH system functions via glutathione peroxidase (GSH-Px) enzymes, which inactivate H 2 O 2 and other hydroperoxides(includingalkylandlipidperoxides)by conversionofGSHtoglutathionedisulfide(GSSG), whichisconvertedbacktoGSHbyglutathionereductase(GR)usingNADPH [21] .Substratespecific cooperation between various antioxidative enzymes andcofactorsarepresentedinFig.1.
In this review, the effects of selected antioxidant enzymes activity on cancer cells proliferation, chemoresistance, invasine and migratory potential of this cells, are presented. Table I shows influence of antioxidantenzymesoverexpression/activityonproliferation, invasion, metastasis and drug resistance phenotypeofcancercellsanin vitro.
ThecorrelationbetweenAOEexpressionandthe clinical outcome of cancer patients has been investigated using biopsy specimens. Studies have docu-mentedhighlevelsofMnSODinmalignanttumors of the mesothelium, stomach, ovary, cervix brain, andthyroid [23] [24] [25] [26] [27] [28] .Pancreaticcancer,however,has been demonstrated to have low activity of antioxidant enzymes [29] . Immunohistochemical studies demonstrated that MnSOD, Cu/ZnSOD, CAT and GSH-Px are decreased in human pancreatic ductal carcinomaspecimenswhencomparedtonormalhuman pancreas. Similar findings are seen in primary pancreaticcancercelllines,includingpancreaticcan-cercelllineMIA,PaCa-2,whichhasdecreasedlevels of MnSOD immunoreactivity and enzyme activity whencomparedtonormalpancreas [30] .
In malignant gliomas, high immunoreactivity of GST,butnotthatofCu/ZnSOD,wasrelatedtothe shortsurvivaltimeafterrecurrenceintumor-bearing patients [31] .Inmalignantmesothelioma,highMn-SOD activity also reduced tumor progression [26] . Ingastriccancers,elevatedexpressionandactivityof MnSODincancercellswerecorrelatedwithapoor overallsurvivalrateincancerpatients [32] .
SOD isoenzymes affect proliferation of cancer cells
SODenzymescanaffecttumorcellproliferationvia theireffectsonperoxidelevels.Decreasedproliferation ofcancercellswithhighactivityofMnSODisoenzyme was observed in U118 and U118-9 human glioma cells [33] and MIA PaCa-2 pancreatic cell carcinoma SOD -superoxide dismutase; CAT -catalase; GSH-Px -glutathione peroxidase; GR -glutathione reductase; γ-GCSγ-glutamylocysteine synthetase; GS -glutamine synthetase; G-6-PD -glucose-6-phophate dehydrogenase [34] U-118humangliomacellline Zhonget al.1997 [33] A172Rratglioma
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Invasive and migratory potential of cancer cells depend on AOE capacity
Recent data indicated that primary tumors and metastaticlesionsareassociatedwithchangesinthe contentandactivityofantioxidantenzymeswithan associated change in growth characteristics depend-ingontheH 2 O 2 concentrations.In vitro studieshave shownthatanumberofcancercelllinescontainelevated levels of mitochondrial manganese-containing superoxidedismutase(MnSOD)anddecreasedactiv-ityofCAT,andthatthischangeinsteadystatelevels ofH 2 O 2 correlateswithincreasedmetastasisandresistancetoapoptosis [43, 44] .Epidemiologicevidence has also linked a single nucleotide polymorphism in theMnSODgene,whichincreasesitsactivity,torisk of developing breast [45] and prostate [46] cancers inpopulationswithapoordietaryantioxidantstatus.
Connoret al. [47] ,usingtheadenoviraltransductionmethod,reportedthatup-regulationofMnSOD is associated with an increased frequency of tumor invasion and metastasis in certain cancers. Overex-pressionandincreasedactivityofMnSODisoenzyme inHT-1080fibrosarcomacellssignificantlyenhanced their migration 2-fold in a wound healing assay andtheirinvasivepotential3-foldinatranswellinvasion assay [47] . This study also showed that the MnSOD-dependent production of H 2 O 2 leads to increased expression of matrix metalloproteinase (MMP) family members and that there is a strong correlationbetweenthisincreaseinMMPlevelsand enhanced metastasis. An essential and rate limiting stepinmetastasisistheremodelinganddegradation oftheextracellularmatrixandbasementmembrane by MMP enzymes. These enzymes are major contributorsofstromaldegradationandarevitaltothe processofcellularinvasion [48] .Anotherstudyperformed by Nelson et al. [49] also revealed that the MnSOD-overexpressingHT-1080celllinedisplayed increased invasive potential by enhanced MMP-1 expression and activity. They also found that the H 2 O 2 -detoxifyingenzymecatalase(CAT)attenuated the MnSOD-dependent increases in MMPs expression. Co-expression of CAT in the MnSOD-overexpressingcancercelllinesreversedtheincreaseininvasivepotentialofthesecells [49] .
Bothstudiesclearlydemonstratedthatthemeta-staticpotentialofHT-1080fibrosarcomacelllinesis enhanced in response to MnSOD overexpression in aH 2 O 2 -dependentmanner.
Increased antioxidant enzyme activities alter drug resistance phenotype
Increased GSH-Px and cofactor GSH, CAT and Trx enzyme metabolism have been known for years tobecorrelatedwithhightumoraggressionandresistancetochemotherapy [50] [51] [52] [53] [54] [55] .Thedevelopment ofdrugresistancetocancerchemotherapyisamajor obstacle to the effective treatment of human malignancies.Ithasbeenestablishedthatmembraneproteins, notably multidrug resistance protein (MRP), playimportantrolesinthedevelopmentofmultidrug resistance(MDR).Moreover,ROSandredoxadaptationtooxidativestresscanaffecttheefficacyofcancer treatmentbymultiplemechanisms,includingchemosensitivityofcancercellstoanticancerdrugs [56] .
Increased levels of ROS in cancer cells may lead tothedevelopmentofredoxadaptationbyincreasing activityofantioxidantenzymessuchasGSH-Pxand CAT.Elevationofantioxidantenzymeactivitiesand survivalsignalsasaresultofredoxadaptationprobablyexplainsthedrugresistancephenotypeofsome cancers cells [16] . For example, the human breast cancer cell line MCF-7/ADR R , selected in vitro for doxorubicinresistance,hasbeenshowntodisplaythe MDRphenotype.Thisresistancemayalsobeduein parttoelevatedlevelsofglutathione-dependentperoxidaseactivity.Peroxidaseactivityinthesecellsisdue mainly to increases in selenium dependent GSH-Px withminorincreasesinnon-seleniumdependentperoxidase.Moreover,decreasedhydroxylradicalforma-tionwasdemonstratedinresistantMCF-7/ADR R cells afteranticanceragentexposure,whencomparedwith the parental strain. Thus, at least in vitro, increased activity of GSH-Px contributes to cellular resistance todoxorubicin [50] .Moreover,highlevelsofreduced glutathione (GSH), the co-factor of GSH-Px, have beenassociatedwithamultidrugresistancephenotype ofsomecancercelllines [56] .Fromthesestudies,sub-sequentdecompositionofhydrogenperoxidebyCAT andGSH-Pxappearstobecriticalintheresistanceof severalcancercellstovariousROS-generatingagents.
SeveralmembersoftheMRPfamilyrequireGSH for transport activities. GSH is the most abundant antioxidant,underscoringtherolesofredoxregulationofmultidrugresistancemediatedbythisgroup ofABCtransporters.TheroleofGSHinMRP-1-mediateddrugsensitivityinculturedcellswasdemon-stratedinMRP-1-overproducingcellsthateffectively effluxdaunorubicinoutsidethecells.Thiseffectwas partially reversed by exposing these cells to buthionine sulfoximine (BSO), an inhibitor of GSH synthesis.TheinfluenceofBSOondrugresistancewas associatedwithdecreasedGSHcontentandincreased intracellularaccumulationofdaunorubicinowingto inhibitionoftheenhanceddrugefflux [52] .Sobhakumariet al. [57] reportedthatinhibitionofGSHand Trxmetabolismenhancedcellkillingofhumanhead andnecksquamouscellcarcinoma(HNSCC)cellsby amechanisminvolvingoxidativestress.Inhibitionof GSH and Trx metabolism with buthionine sulfoximine (BSO) and auranofin (AUR) (inhibitor of TR enzyme), respectively, induced significant decreases inclonogenicsurvivalcomparedtoeitherdrugalone in FaDu, Cal-27 and SCC-25 HNSCC cells in vitro andin vivoinCal-27xenografts [57] .
AOEs activity and cancer cell survival and resistance to chemotherapeutic drugs
Increased GSH-Px activity also enables cells to survivewithahighlevelofROSandmaintaincellu-larviability.Furthermore,theincreaseinglutathione during the adaptation process can enhance the exportofanticancerdrugsandtheirinactivation.This altered drug metabolism together with enhanced cell survival may render cancer cells more resistant to chemotherapeutic agents [16] . Increased activity ofGSH-PxorCATincancercellscanmaketumor cellslesssusceptibletotheeffectsofanticancerdrugs, such as doxorubicin-mediated damage. It has been demonstratedthattheadditionofradicalscavengers andcompoundswithperoxideactivitycanreducethe cytotoxiceffectofanticancerdrugsin vitro [7] .Samuels et al. [58] demonstrated increased doxorubicin sensitivity in the STSAR90 sarcoma tumor cell line in comparison to the STSAR11 wild cell line. Total GSH-Px activity in STSAR90 cells was approximately 6-fold higher than in STSAR11 cells. These results indicate that multidrug resistance due to P-glycoprotein-mediateddrugeffluxisnottheonly mechanism of doxorubicin resistance that occurs in sarcomasandthatGSH-Px-dependentdetoxification ofdoxorubicin-inducedoxygenradicalsmaycontributetoclinicaldoxorubicinresistance [58] .Likewise, severalstudiessuggestthattheresistancetoagents that induce intracellular ROS production, such as paclitaxel,doxorubicinandplatinumcompounds,is correlated with increased antioxidant capacity [12, 16] . Moreover, H-Ras transformed cells which exhibitedincreasedhydrogenperoxideandsuperoxide levelswereshowntoexpresshigherlevelsofantioxidant enzyme such as thioredoxin peroxidase. Their enhancedantioxidantdefensesystemislikelytoserve asakeymechanismtoevadeROS-inducedapoptosis. Ras-transformed cells were also found to be more sensitivetodepletionofglutathione(GSH),leading to ROS accumulation and cell death [59] , suggestingacrucialroleofantioxidantenzymeactivitiesin cancer cell survival. Studies using inducible c-Myc inmelanomacellsshowedthatc-Myccontrolledthe expressionoftheGSHsynthesisenzyme.Apoptosis inducedbydownregulationofc-Myc wasassociated withcellulardepletionofreducedGSH [60] .These datasuggestthatcellswithactivec-Myc maysurvive ROSstressbyup-regulatingGSHsynthesis.
Thusitisconceivablethatduringmalignanttransformation the oncogenic signals both induce ROS generationtostimulatecellproliferationthroughredox-sensitivetranscriptionalfactorsandpromoteox-idativeadaptationtominimizecellularROSdamage.
The mechanism of the redox adaptation process mayinvolvemultiplepathwaystoactivateredox-sensitivetranscriptionfactorssuchasnuclearfactor-κβ, Nrf2,c-JunandHIF-1α,whichleadtoincreasedex-pressionofantioxidantmoleculessuchasSOD,cat-alaseandGSH-Px,andtheGSHantioxidantsystem [16] .TheseredoxsensitiveTFsalsoregulatetheexpressionofproteinsthatareinvolvedinproliferation, immortalization, angiogenesis and metastasis, thus providingafurthersurvivaladvantage [61] .
GSH-Px and lipid peroxidation
Lipid peroxidation is one of the most investigated consequences of ROS' actions on membrane structureandfunction.Ithasbeenshownthatlipidhydroperoxidesandoxygenatedproductsoflipid peroxidation degradation participate in the signal transduction cascade [62] , the control of cell proliferation,andtheinductionofdifferentiation,maturation,andapoptosis [63, 64] .Ithasbeenshown that lipid peroxidation and ROS are triggers and essential mediators of apoptosis, which eliminates precancerous and cancerous, virus-infected and otherwise damaged cells that threaten our health. ROSreactwithpolyunsaturatedfattyacidresidues in phospholipids, resulting in the production of a plethora of products, many of them reactive to-wardproteinandDNA [65] .
One of the most abundant carbonyl products of lipidperoxidationismalondialdehyde(MDA),which alsoreactswithDNAtoformadductstodeoxyguanosine,deoxyadenosine,anddeoxycytidine [66] .
GSH-Px is an enzyme which reduces not only hydrogenperoxidebutalsoorganicsuperoxides.In such reactions an organic superoxide (ROOH) becomesreducedtoanappropriatealcohol(ROH).In thecaseoflipidsuperoxide,thismeansthatitcannot becomeaninitiatoroflipidperoxidation,andtherefore glutathione peroxidase inhibits lipid peroxidation [67] .
Lipid peroxidation appears to be a major source of endogenous DNA damage in humans that may contributesignificantlytocancer.
ROS-mediated treatment of cancer as a therapeutic strategy
To exploit the ROS mediated cell-death mechanism as a therapeutic strategy, it is possible to combine drugs that induce ROS production with compoundsthatsuppressthecellularantioxidantcapacity.Thisapproachmightbeparticularlyusefulin drug-resistantcancercells.Forexample,buthionine sulfoximine(BSO),aglutathionesynthesisinhibitor, can increase the cytotoxicity of melphalan by preventingglutathioneperoxidaseactivityandincreas-ingH 2 [8] one precursor N-acetylcysteine (NAC), which can functiondirectlyinthedetoxificationofH 2 O 2 andas athioldonortoprotectcriticalsulfhydrylgroupsin cell proteins, also prevented the hematological toxicityofpaclitaxel.Ontheotherhand,mangafodipir, butnotNACappearstoimprovethetherapeuticactivity of this chemotherapeutic agent against CT26 mouse colon cancer cells in vivo. These chemical compounds also protected normal leukocytes from the toxic effects of oxaliplatin and 5-fluorouracil in vitro.Becausemangafodipiriswidelyused,thisdrug mightbeappropriateforstudyasachemoprotective compoundinhumantrials [12, 69, 70] .
On the other hand, hydrogen peroxide is also knownasastrongoxidantthatinducesapoptosisof tumorcellsin vitro [3, 71] .PerhapsH 2 O 2 aloneisrelativeunstableandisasmallwater-solublemolecule. ThesecharacteristicshampertheutilityofH 2 O 2 asan antitumoragentthatmightbeselectivelydelivered tothetumor.Infact,H 2 O 2 usedalonewasineffectivewheninjectedintoatumororintothecirculation [72, 73] ,perhapsbecauseofitsrapidclearanceand decompositionbycatalaseinerythrocytes.Useofan H 2 O 2 -generating enzyme has been proposed as an alternativeapproachtodevelopinganH 2 O 2 -dependentantitumortreatment.Fanget al. [73] reported thatGO,whichgeneratesH 2 O 2 duringoxidationof glucose, showed antitumor activity in solid tumor models. However, regulation of H 2 O 2 production by exogenously administered GO in tumor-bearing hosts is problematic because the availability of its substrates, oxygen and glucose, cannot be significantly modulated with the possible induction of severe systemic side effects due to systemic H 2 O 2 production. In fact, GO administration to produce H 2 O 2 requiredinjectionofantioxidantstominimize systemictoxicity.MoroverFangandco-workersdelivered to tumor-bearing mice polyethylene glycol conjugatedwithD-aminoacidoxidase(PEG-DAO). DAO is a flavoprotein that catalyzes the stereoselective oxidative deamination of D-amino acids to the corresponding alpha keto acids. During this oxidation reaction, molecular oxygen is used as an electronacceptor,andH 2 O 2 isgenerated.DAOactivity and hence generation of H 2 O 2 was regulated byexogenousadministrationofD-aminoacids.Fang andco-workersinfirsttimetreatmentadministered PEG-DAOi.v.totumor-bearingmice.Afteranadequate lag time, the substrate of DAO, D-proline, was injected i.p. This treatment resulted in significant suppression of tumor growth compared with tumorgrowthincontrolanimals [73] .
In conclusions: Modulation of ROS production mightbeapromisingapproachtoincreaseanticancer agentscytotoxicity.
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